Intel stock falls 5% in premarket amid broader tech selloff
Intel Corp (NASDAQ: INTC) shares declined 4.64% in premarket trading to $98.69, aligning with a broader technology sector selloff where Nasdaq futures fell 1.24%. Bank of America maintains a Buy rating with a $145 target, projecting Intel Foundry revenue could reach $40 billion by 2030. Technical indicators show the stock consolidating below its 50-day SMA but well above its 200-day SMA, suggesting long-term strength amid short-term weakness.

*this image is generated using AI for illustrative purposes only.
Intel Corp (NASDAQ: INTC) shares fell 4.64% to $98.69 in Tuesday’s premarket trading, mirroring a broader retreat across technology equities. The decline was driven by risk-off sentiment ahead of the market open, with Nasdaq futures down 1.24% and S&P 500 futures shedding 0.41%.
The premarket drop appears linked to sector-wide pressure rather than company-specific news. Investors are reducing exposure to higher-beta technology stocks, creating headwinds for Intel as it continues significant capital deployment into manufacturing capabilities.
Analyst Outlook
Bank of America remains bullish on Intel’s foundry business following the company’s approximately $20 billion equity raise. Analyst Vivek Arya noted that the capital raise signals management confidence in internal demand and external customer interest, despite expected near-term earnings dilution.
BofA projects Intel Foundry revenue could grow from about $1.1 billion in 2026 to nearly $40 billion by 2030, potentially capturing 8% to 10% of the estimated $380 billion wafer foundry market.
Recent Ratings Actions
- Bank of America: Buy rating; price forecast lowered to $145 on Aug. 12.
- UBS: Neutral rating; price forecast lowered to $112 on Aug. 12.
- Bank of America: Buy rating; $160 price forecast maintained on July 28.
The consensus rating among 50 analysts is Hold, with an average price forecast of $110. Forecasts range from $71 to $155.
Technical Analysis
Intel’s long-term trend remains positive, but intermediate momentum has weakened. The stock trades 40.2% above its 200-day simple moving average (SMA) of $70.45, yet sits 9.6% below its 50-day SMA of $109.24. This positioning suggests consolidation after a strong advance rather than a sustained short-term uptrend.
The relative strength index (RSI) stands at 52.50, indicating neutral conditions without overbought or oversold signals. The 20-day SMA of $97.15 remains below the 50-day SMA, signaling near-term weakness, while the 50-day SMA stays above the 200-day SMA, supporting the longer-term bullish structure.
Key support is identified at $89.50, a level where buyers previously intervened. The stock reached a 52-week high in June before pulling back to a swing low in July.
What the Numbers Show
Intel’s technical setup reveals a divergence between long-term and short-term momentum. While the stock remains significantly above its 200-day SMA (+40.2%), it trades below its 50-day SMA (-9.6%). This gap highlights that while the primary trend is intact, recent price action has failed to sustain momentum near recent highs, resulting in a consolidation phase rather than continued upward movement.
ETF Exposure
Intel holds significant weightings in several major exchange-traded funds, meaning fund flows can influence stock volatility:
| ETF Name | Ticker | Weighting |
|---|---|---|
| State Street SPDR NYSE Technology ETF | XNTK | 5.86% |
| iShares Semiconductor ETF | SOXX | 5.53% |
| iShares MSCI USA Momentum Factor ETF | MTUM | 5.12% |
Intel’s Benzinga Edge Momentum score stands at 98.66, reflecting strong prior price performance despite the current pullback.
How might Intel's heavy capital deployment into manufacturing impact its near-term free cash flow and dividend sustainability amidst the current sector-wide risk-off sentiment?
Given Bank of America's projection of $40 billion in foundry revenue by 2030, what specific external customer wins or technological breakthroughs are required to capture the targeted 8-10% market share?
With the stock trading below its 50-day SMA but above its 200-day SMA, does the current consolidation phase signal a healthy correction before further upside, or is it indicative of a deeper trend reversal?
































